Par Drugs & Chemical P/B Ratio
Par Drugs & Chemical (PAR) P/B ratio is 1.04 (Moderate), book value per share ₹93.33 vs Healthcare average P/B of -0.35 — Moderate - Reasonably valued relative to book value. Compare with Par Drugs & Chemical valuation methods to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
PAR P/B Ratio — Valuation Insights & Book Value Analysis
Par Drugs & Chemical price-to-book ratio interpretation, valuation status and historical context — current P/B 1.04 (Moderate). For live price, earnings yield and the full fundamental profile, see Par Drugs & Chemical share price today.
- Trading at premium to sector average PB of -0.35
Par Drugs & Chemical P/B Ratio Historical Trend
PAR annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Par Drugs & Chemical yearly highs lows for the annual high/low range and current price position.
PAR Historical P/B Ratio — Book Value Per Share & Year-End Price
Par Drugs & Chemical annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.98 | ₹93.33 | ₹91.00 | ₹112 | Low |
| 2025 | 1.23 | ₹82.5 | ₹101.26 | ₹99 | Moderate |
PAR vs Healthcare Peers — P/B Ratio Comparison
Par Drugs & Chemical P/B 1.04 vs Healthcare average -0.35, median 0.61 — range -18.41–1.12.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -3.86 | ₹27 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |